Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Epidural Stimulation After Neurologic Damage

NCT: NCT03026816 · RECRUITING

NCT IDNCT03026816
StatusRECRUITING
Start Date2017-08-07
Completion2028-01

Brief Summary

This study will evaluate a method to optimize parameter settings in epidural spinal cord stimulation used to recover lower extremity volitional movement. The study will also characterize improvement in autonomic function (such as blood pressure control) and other functions related to spinal cord injury.

Frequently Asked Questions

What is Epidural Stimulation After Neurologic Damage?

Epidural Stimulation After Neurologic Damage is a clinical trial registered under NCT03026816. Current status: RECRUITING.

What is the status of NCT03026816?

The current status of NCT03026816 (Epidural Stimulation After Neurologic Damage) is: RECRUITING.

When did Epidural Stimulation After Neurologic Damage start?

Epidural Stimulation After Neurologic Damage started on 2017-08-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑